newsfilter
← Latest News
GlobeNewswire·

Immunocore to report fourth quarter and full year 2024 financial results and host call on February 26, 2025

(OXFORDSHIRE, England & CONSHOHOCKEN, Penn. & GAITHERSBURG, Md., US, 19 February 2025) Immunocore Holdings plc (NASDAQ:IMCR) ("Immunocore" or the "Company"), a commercial-stage biotechnology company pioneering